Michael Hunter

Abbott Toxicology Ltd. provides drug and alcohol testing products and services. It offers advisory services and testing capabilities, including laboratory testings, point of care tests and sample types for any biological specimen, including urine, oral fluids, hair and sweat. The company was founded in 2005 and is headquartered in Abingdon, the United Kingdom.

Renewable Energy Systems Ltd. develops, designs, and constructs wind farms, renewable heat, and power installations. The firm offers solar farms, transmission lines, and energy storage services. It also provides demand side management, project development, measurement, engineering, construction, legal and commercial package, and asset management services. The company was founded in 1981 and is headquartered in Kings Langley, the United Kingdom.

Part of BBI Diagnostics Group Ltd., British Biocell International Ltd. is a private group led by Julian Baines. The company is based in Cardiff, UK. British Biocell International was acquired by BBI Diagnostics Group Ltd. on January 31, 2001.

Hall Chadwick is a national association of Chartered Accounting and Business Advisory firms that provides a balanced view of business and private wealth. Hall Chadwick is based in Sydney, Australia and has subsidiaries in Australia. The Australian company offers wealth management advisory services to help clients create and build wealth while reducing their exposure to risk.

Part of Johnson Matthey Plc, Johnson Matthey Fuel Cells Ltd. is a British company that manufactures and markets fuel cell components. The company is based in Swindon, UK and was founded in 2000.

Shell International Renewables BV markets and distributes alternative energy products. The company offers equipment for the production of power from the biofuels, hydrogen, sun, the wind, and moving water. Shell International Renewables was founded in 1997 and is headquartered in The Hague, The Netherlands.

ApaTech Ltd. develops synthetic bone graft technology. It specializes in producing synthetic bone repair material. The company has developed a novel silicate substituted calcium phosphate bone graft material, Actifuse, which underpins the company's leadership in applying the science of silicon to bone graft technologies. Actifuse is the first of a new class of synthetic bone graft materials that combine osteoconductive, osteostimulatory and bioactive qualities resulting in accelerated bone growth. The company was founded in 2001 and is headquartered in Elstree, UK.

Molecular Vision Ltd. develops low-cost, lab-quality, point of care, disposable diagnostic devices for medical testing. The company was founded by Donal D. C. Bradley in 2001 and is headquartered in York, the United Kingdom.

Brandon Capital Partners Pty Ltd. (Brandon Capital Partners) is a venture capital firm founded in 2007 by David Fisher and Chris Nave. The firm is headquartered in Sydney, Australia.

Part of AptarGroup, Inc., Aptar UK Ltd. is a company that manufactures plastics packaging products. Aptar UK Ltd. is based in Leeds, UK. Founded in 1979.

Forsite Diagnostics Ltd. engages in the manufacture of diagnostic usage equipment. The company was founded on February 3, 2006 and is headquartered in York, the United Kingdom.

Part of Abingdon Health Plc, Serascience Ltd provides diagnostic services. The company is based in Nottingham, UK. Serascience was acquired by Abingdon Health Plc from Bioscience Ventures Ltd. on October 13, 2014 for $3.37 million.

Artios Pharma Ltd. manufactures pharmaceutical products. The firm develops a DNA Damage Response (DDR) is a cancer therapy. The company was founded by Niall Martin in May 2016 and is headquartered in London, the United Kingdom.

BBI Solutions OEM Ltd. develops and manufactures raw materials and finished test platforms for the in-vitro diagnostics market. It offers gold reagents, antibodies, antigens, biobank, cell culture, reagents, and enzymes. The firm services include lateral flow assay development, lateral flow test manufacture, and case studies. The company was founded in John Chandler in 1986 and is headquartered in Cardiff, the United Kingdom.

Depixus SAS is a life science technology company based in Paris, France. Depixus is pioneering ground-breaking magna™ technology based on magnetic force spectroscopy, revealing dramatic new insights into complex biomolecular interactions at the single molecule level. The French company was founded by Gordon Hamilton and has been the CEO since incorporation.

Part of Novo Nordisk Fonden, Eagle SPV 2 Ltd. is an investment holding British company. The company is based in Cardiff, UK. Eagle SPV 2 was founded in 2015.

Part of Novo Nordisk Fonden, Eagle SPV 3 Ltd. is a British company that provides professional, scientific and technical services. The company is based in Cardiff, UK. Eagle SPV 3 was founded in 2015.

Part of The Manufacturing Technology Centre Ltd., Business Launch Centre Ltd. manufactures incubators and provides management consulting services. The company is based in Coventry, UK. Founded in 2014.

Part of Novo Nordisk Fonden, BBI Enzymes (USA) Ltd. is a British company that manufactures chemical products. The company is based in Cardiff, UK. BBI Enzymes (USA was founded in 1985.

Autism Research Trust provides health care services. The private company is based in Leeds, UK. The CEO of the British company is Marie Davies.

Part of BBI Diagnostics Group Ltd., BBI Resources Ltd. is a staffing services provider. The company is based in Cardiff, UK. BBI Resources was founded in 2013.

STipe Therapeutics ApS operates as a biotechnology company. It specializes in the immune-oncology field, pioneer therapies using a novel aspect of the stimulator of interferon genes (STING) Pathway to target cancer. The company was founded in 2018 and is headquartered in Denmark.

Novarum Dx Ltd. is a British company that specializes in point of care testing with smartphones. Novarum Dx is based in Cardiff, UK. The private company is pioneers in reading lateral flow tests with a phone and offer a complete solution for reading, recording, and reporting test results without requiring AI or other mysterious black boxes.

NRG Therapeutics Ltd. is a British neuroscience drug discovery company that focuses on building a pipeline of disease-modifying mitochondrial therapeutics to slow or halt the progression of neurodegenerative disorders such as Parkinson's and ALS. The company is based in Stevenage, UK, and was founded in 2018 by Neil Miller and Richard Rutter. The company's pre-clinical pipeline of small molecule assets is based on inhibiting the mitochondrial permeability transition pore (mptp) through a novel mechanism of action. Inhibition of the mptp has been shown to protect neurons, reduce neuroinflammation, and extend survival in pre-clinical disease models. Neil Miller has been the CEO since 2018.

Pheon Therapeutics Ltd. is an antibody drug conjugate (ADC) specialist that develops a pipeline of monotherapies for novel targets and/or with novel payloads. The company is based in Harpdenden, UK. The British company's lead program is a first-in-class ADC against a novel target that is highly expressed in solid tumors across a broad range of hard-to-treat cancer types. ADCs offer the potential to treat solid tumors and liquid cancers that have not responded to other treatments. The company was founded in 2015 by Paul Jackson. Cyrus D. Mozayeni has been the CEO of the company since 2023.